Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Michiels

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
NPJ Vaccines|March 9, 2022
Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variantKevin K Ariën, Leo Heyndrickx, Johan Michiels, et al.
Scientific Reports|October 11, 2016
CD4-mimetic sulfopeptide conjugates display sub-nanomolar anti-HIV-1 activity and protect macaques against a SHIV162P3 vaginal challengeKevin K Ariën, Françoise Baleux, Delphine Desjardins, et al.
Clinical and Vaccine Immunology : CVI|March 13, 2015
Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and PreventionJordan K Kyongo, Tania Crucitti, Joris Menten, et al.
NAR Genomics and Bioinformatics|January 12, 2026
SquiDBase: a community resource of raw nanopore data from microbesWim L Cuypers, Halil Ceylan, Eline Turcksin, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 25, 2023
Severe mpox (formerly monkeypox) disease in five patients after recent vaccination with MVA-BN vaccine, Belgium, July to October 2022Nicole Berens-Riha, Tessa De Block, Jojanneke Rutgers, et al.
Cancer Cell|February 16, 2022
Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipientsLorenzo Canti, Kevin K Ariën, Isabelle Desombere, et al.
Journal of Medical Virology|May 22, 2023
Presymptomatic viral shedding in high-risk mpox contacts: A prospective cohort studyIsabel Brosius, Christophe Van Dijck, Jasmine Coppens, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 11, 2023
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipientsDelphine Kemlin, Nicolas Gemander, Stéphanie Depickère, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 22, 2022
A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunitySean McCafferty, A K M Ashiqul Haque, Aster Vandierendonck, et al.
Journal of Hematology & Oncology|October 25, 2021
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipientsLorenzo Canti, Stéphanie Humblet-Baron, Isabelle Desombere, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
NPJ Vaccines|March 9, 2022
Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variantKevin K Ariën, Leo Heyndrickx, Johan Michiels, et al.
Scientific Reports|October 11, 2016
CD4-mimetic sulfopeptide conjugates display sub-nanomolar anti-HIV-1 activity and protect macaques against a SHIV162P3 vaginal challengeKevin K Ariën, Françoise Baleux, Delphine Desjardins, et al.
Clinical and Vaccine Immunology : CVI|March 13, 2015
Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and PreventionJordan K Kyongo, Tania Crucitti, Joris Menten, et al.
NAR Genomics and Bioinformatics|January 12, 2026
SquiDBase: a community resource of raw nanopore data from microbesWim L Cuypers, Halil Ceylan, Eline Turcksin, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 25, 2023
Severe mpox (formerly monkeypox) disease in five patients after recent vaccination with MVA-BN vaccine, Belgium, July to October 2022Nicole Berens-Riha, Tessa De Block, Jojanneke Rutgers, et al.
Cancer Cell|February 16, 2022
Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipientsLorenzo Canti, Kevin K Ariën, Isabelle Desombere, et al.
Journal of Medical Virology|May 22, 2023
Presymptomatic viral shedding in high-risk mpox contacts: A prospective cohort studyIsabel Brosius, Christophe Van Dijck, Jasmine Coppens, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 11, 2023
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipientsDelphine Kemlin, Nicolas Gemander, Stéphanie Depickère, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 22, 2022
A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunitySean McCafferty, A K M Ashiqul Haque, Aster Vandierendonck, et al.
Journal of Hematology & Oncology|October 25, 2021
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipientsLorenzo Canti, Stéphanie Humblet-Baron, Isabelle Desombere, et al.
Pageof 5